05 Feb 2014, BioSpectrum Bureau , BioSpectrum
Singapore: US-based Harlan Laboratories, a leading contract research organization (CRO) and research models and services company, has appointed Ms Urvashi Gupta as director of business development for its research models and services (RMS) business unit in Asia.
Ms Gupta will focus on expanding Harlan's market position and growth by fostering new business initiatives, driving key strategic partnerships and leading corporate development efforts. She will also oversee a team of business development managers in Japan and Korea, and will have responsibility for agents in mainland China, Singapore, Hong Kong, Malaysia and Australia.
"As the preclinical research market continues to establish roots and grow outside of North America and Europe, now is the perfect time to expand our already talented business development group," said Mr Stuart Frith, global VP, Business Development at Harlan Laboratories.
"We're excited to add Urvashi to our team, and her wealth of international experience in the CRO and pharmaceutical industries will be an asset to Harlan as we continue to expand in Asia," he added.